NCAM(CD56) and RUNX1(AML1) are up-regulated in human ischemic cardiomyopathy and a rat model of chronic cardiac ischemia

American Journal of Pathology

Volumn 163, Issue 3, 2003, Pages 1081-1090

  Gattenlöhner, Stefan ^a   Waller, Christiane ^a   Ertl, Georg ^a   Bültmann, Burkhard Dieter ^b   Müller Hermelink, Hans Konrad ^a   Marx, Alexander ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; NERVE CELL ADHESION MOLECULE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; DNA LIBRARY; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE OVEREXPRESSION; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN TISSUE; ISCHEMIC HEART DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN INDUCTION; RAT; TRANSCRIPTION REGULATION;

EID: 0042425703     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63467-0     Document Type: Article

References (37)

1. Gheorghiade M, Bonow RO: Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation 1998, 97:282-289
2. Bourassa MG, Gurne O, Bangdiwala SI, Ghali JK, Young JB, Rousseau M, Johnstone DE, Yusuf S: Natural history and patterns of current practice in heart failure: the Studies of Left Ventricular Dysfunction (SOLVD) Investigators. J Am Coll Cardiol 1993, 22:14A-19A
3. Williams JF BM, Fowler MB, Francis GS, Garson A Jr, Gersh BJ, Hammer DF, Hlatky MA, Leier CV, Packer M, Pitt B, Ullyot DJ, Wexler LF, Winters W Jr, Ritchie JL, Cheitlin MD, Eagle KA, Gardner TJ, Gibbons RJ, Lewis RP, O'Rourke RA, Ryan TJ: Guidelines for the evaluation and management of heart failure: report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure). Circulation 1995, 92:2764
4. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P: Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 1996, 93:841-842
5. Felker GM, Shaw LK, O'Connor CM: A standardized definition of ischemic cardiomyopathy for use in clinical research. J Am Coll Cardiol 2002, 39:210-218
6. Tenenbaum A, Fisman EZ, Motro M: Toward a redefinition of ischemic cardiomyopathy: is it an indivisible entity? J Am Coll Cardiol 2002, 40:205-206
7. Benedict CR, Johnstone DE, Weiner DH, Bourassa MG, Bittner V, Kay R, Kirlin P, Greenberg B, Kohn RM, Nicklas JM, McIntyre K, Quinones MA, Yusut S, for the SOLVD Investigators: Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: a report from the registry of Studies of Left Ventricular Dysfunction (SOLVD) Investigators. J Am Coll Cardiol 1994, 23:1410-1420
8. Benedict CR: Neurohumoral aspects of heart failure. Cardiol Clin 1994, 12:9-23
9. Lerman A, Hildebrand FL, Jr., Aarhus LL, Burnett JC Jr: Endothelin has biological actions at pathophysiological concentrations. Circulation 1991, 83:1808-1814
10. McMurray JJ, Ray SG, Abdullah I, Dargie HJ, Morton JJ: Plasma endothelin in chronic heart failure. Circulation 1992, 85:1374-1379
11. Mann DL, Young JB: Basic mechanisms in congestive heart failure: recognizing the role of proinflammatory cytokines. Chest 1994, 105:897-904
12. Torre-Amione G, Kapadia S, Lee J, Durand JB, Bies RD, Young JB, Mann DL: Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation 1996, 93:704-711
13. Schreiner GF: Immune modulation of cardiac cell function. Trans Am Clin Climatol Assoc 1998, 109:39-49
14. Vadlamani L, Abraham WT: Insights into pathogenesis and treatment of cytokines in cardiomyopathy. Curr Cardiol Rep 2000, 2:120-128
15. Kloner RA, Jennings RB: Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 2. Circulation 2001, 104:3158-3167
16. Heads RJ, Latchman DS, Yellon DM: The molecular basis of adaptation to ischemia in the heart: the role of stress proteins and anti-oxidants in the ischemic and reperfused heart. EXS 1996, 76:383-407
17. Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadaro J, Kloner RA, Braunwald E: Myocardial infarct size and ventricular function in rats. Circ Res 1979, 44:503-512
18. Sambrook JFE, Maniatis T: Molecular Cloning, vol 3. New York, Cold Spring Harbor Press, 1989, pp 18.60-18.78
19. Gattenloehner S, Vincent A, Leuschner I, Tzartos S, Muller-Hermelink HK, Kirchner T, Marx A: The fetal form of the acetylcholine receptor distinguishes rhabdomyosarcomas from other childhood tumors. Am J Pathol 1998, 152:437-444
20. Takahashi A, Satake M, Yamaguchi-Iwai Y, Bae SC, Lu J, Maruyama M, Zhang YW, Oka H, Arai N, Arai K, Ito Y: Positive and negative regulation of granulocyte-macrophage colony-stimulating factor promoter activity by AML1-related transcription factor, PEBP2. Blood 1995, 86:607-616
21. Hwang DM, Dempsey AA, Lee CY, Liew CC: Identification of differentially expressed genes in cardiac hypertrophy by analysis of expressed sequence tags. Genomics 2000, 66:1-14
22. Zhu X, Yeadon JE, Burden SJ: AML1 is expressed in skeletal muscle and is regulated by innervation. Mol Cell Biol 1994, 14:8051-8057
23. Grumet M, Rutishauser U, Edelman GM: Neural cell adhesion molecule is on embryonic muscle cells and mediates adhesion to nerve cells in vitro. Nature 1982, 295:693-695
24. Edelman GM: Cell adhesion molecules in neural histogenesis. Annu Rev Physiol 1986, 48:417-430
25. Rutishauser U, Grumet M, Edelman GM: Neural cell adhesion molecule mediates initial interactions between spinal cord neurons and muscle cells in culture. J Cell Biol 1983, 97:145-152
26. Gordon L, Wharton J, Moore SE, Walsh FS, Moscoso JG, Penketh R, Wallwork J, Taylor KM, Yacoub MH, Polak JM: Myocardial localization and isoforms of neural cell adhesion molecule (N-CAM) in the developing and transplanted human heart. J Clin Invest 1990, 86:1293-1300
27. al-Mahdawi S, Shallal A, Wyse RK: Neural cell adhesion molecule (N-CAM) in fetal and mature human heart. FEBS Lett 1990, 267;183-185
28. Krushel LA, Cunningham BA, Edelman GM, Crossin KL: NF-κB activity is induced by neural cell adhesion molecule binding to neurons and astrocytes. J Biol Chem 1999, 274:2432-2439
29. Zhang YW, Bae SC, Huang G, Fu YX, Lu J, Ahn MY, Kanno Y, Kanno T, Ito Y: A novel transcript encoding an N-terminally truncated AML1/ PEBP2 αB protein interferes with transactivation and blocks granulocytic differentiation of 32Dcl3 myeloid cells. Mol Cell Biol 1997, 17:4133-4145
30. Levanon D, Glusman G, Bangsow T, Ben-Asher E, Male DA, Avidan N, Bangsow C, Hattori M, Taylor TD, Taudien S, Blechschmidt K, Shimizu N, Rosenthal A, Sakaki Y, Lancet D, Groner Y: Architecture and anatomy of the genomic locus encoding the human leukemia-associated transcription factor RUNX1/AML1. Gene 2001, 262:23-33
31. Aziz-Aloya RB, Levanon D, Karn H, Kidron D, Goldenberg D, Lotem J, Polak-Chaklon S, Groner Y: Expression of AML1-d, a short human AML1 isoform, in embryonic stem cells suppresses in vivo tumor growth and differentiation. Cell Death Differ 1998, 5:765-773
32. Tanaka T, Tanaka K, Ogawa S, Kurokawa M, Mitani K, Nishida J, Shibata Y, Yazaki Y, Hirai H: An acute myeloid leukemia gene, AML1, regylates hemopoietic myeloid cell differentiation and transcriptional activation antagonistically by two alternative spliced forms. EMBO J 1995, 14:341-350
33. Kanno S, Saffitz JE: The role of myocardial gap junctions in electrical conduction and arrhythmogenesis. Cardiovasc Pathol 2001, 10:169
34. Kanno S, Kovacs A, Yamada KA, Saffitz JE: Connexin43 as a determinant of myocardial infarct size following coronary occlusion in mice. J Am Coll Cardiol 2003, 41:681-686
35. Petrich BG, Gong X, Lerner DL, Wang X, Brown JH, Saffitz JE, Wang Y: c-Jun N-terminal kinase activation mediates down-regulation of connexin43 in cardiomyocytes. Circ Res 2002, 91:640-647
36. Witzemann V, Barg B, Nishikawa Y, Sakmann B, Numa S: Differential regulation of muscle acetylcholine receptor γ- and ε-subunit mRNAs. FEBS Lett 1987, 223:104-112
37. Gattenlohner S, Schneider C, Thamer C, Klein R, Roggendorf W, Gohlke F, Niethammer C, Czub S, Vincent A, Muller-Hermelink HK, Marx A: Expression of foetal type acetylcholine receptor is restricted to type 1 muscle fibres in human neuromuscular disorders. Brain 2002, 125:1309-1319